Neonatal Abstinence Syndrome (NAS) Non-Pharmacological Treatment - Quality

Neonatal Abstinence Syndrome (NAS) Non-Pharmacological Treatment - Quality Banner

Add to Calendar Neonatal Abstinence Syndrome (NAS) Non-Pharmacological Treatment - Quality 5/20/2019 2:27:36 PM 12/31/2021 11:59:00 PM America/New_York Online false MM/DD/YYYY


Date & Location
Monday, May 20, 2019, 2:27 PM - Friday, December 31, 2021, 11:59 PM

Target Audience
Neonatology

Overview
There is currently an epidemic of Neonatal Abstinence Syndrome (NAS) and there are no robust data regarding optimal treatment. This presentation will address non-optimal, non-pharmacologic care practices for opioid exposed infants during the hospitalization after delivery.

Objectives

Following this educational activity, participants should be able to:
  1. Discuss the impact of breastfeeding and rooming-in on improving NAS outcomes.
  2. List QI interventions towards implementing NAS non-pharmacological care bundles.

Accreditation

The MEDNAX Center for Research, Education, Quality and Safety is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The MEDNAX Center for Research, Education, Quality and Safety designates this Enduring Material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The MEDNAX Center for Research, Education, Quality and Safety is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. (#PO258)

The MEDNAX Center for Research, Education, Quality and Safety designates this Enduring Material for a maximum of 0.50 nursing contact hour(s). Participants should only claim credit commensurate with the extent of their participation in the activity.


Keywords:
  • ONLINE
  • CME
  • CNE
  • Opioid